Skip to main content

Loading market data...

MRK

Merck & Co., Inc.

NYSE • United states

$149.88

+$1.58

(+1.07%)

Source: Yahoo Finance · Quote time Oct 21, 2026 20:04 GMT+0000

Catalyst Evidence

No verified catalyst stored yet

Click “View” to see the stored chain of evidence (if available).

Management
Credibility
Score

Merck & Co., Inc. (MRK)

Unavailable

Quotes may be delayed

$369.78B

Market Cap

9,004,057

Volume

116.5

P/E Ratio

2.29%

Div Yield

Merck & Co., Inc. Price Chart

Loading price history…

Management Credibility Analysis

Unavailable

Verified Management Score Unavailable

Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed

Verified Catalysts Unavailable

No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive: Not disclosed
Headquarters: 126 EAST LINCOLN AVENUE, RAHWAY, NJ
Founded: Not disclosed

📈 Company Timeline

Major business events

Positive

Negative

Neutral

15 Oct 2026

Merck & Co., Inc. filed Form 25-NSE

Merck & Co., Inc. submitted Form 25-NSE to the SEC.

13 Oct 2026

Merck & Co., Inc. reported A director or senior management change or compensation event

Merck & Co., Inc. filed an 8-K covering a director or senior management change or compensation event.

8 Aug 2026

Merck & Co., Inc. filed Form 10-Q

Merck & Co., Inc. submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.

4 Aug 2026

Merck & Co., Inc. reported Operating or financial results

Merck & Co., Inc. filed an 8-K covering operating or financial results, supporting financial statements or exhibits.

29 May 2026

Merck & Co., Inc. reported Shareholder voting results

Merck & Co., Inc. filed an 8-K covering shareholder voting results.

Capital Structure & Financial Position

Financial strength and liquidity analysis

Cash and equivalents (USD)$6.85B

Total assets (USD)$129.80B

Shareholders' equity (USD)$41.93B

Long-term debt (USD)$51.08B

Debt due within a year (USD)$2.83B

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated 30 Jun 2026

Peer Comparison - Health Care

Company	Price	Market Cap
LLY - Eli Lilly and Company	$1,276.13 Yahoo Finance	$1.20T
JNJ - Johnson & Johnson	$256.74 Yahoo Finance	$618.71B
ABBV - AbbVie Inc.	$284.80 Yahoo Finance	$503.28B
UNH - UnitedHealth Group Incorporated	$418.43 Yahoo Finance	$375.58B
PM - Philip Morris International Inc.	$197.46 Yahoo Finance	$307.76B

📋 Corporate Actions

Recent and upcoming corporate events

Verified Corporate Actions Unavailable

Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis

Quarter	Revenue (USD)	Operating income	Net income	Diluted EPS (USD)	Filed
Q2 2026	$16.61B	Unavailable	−$1.34B	−$0.54	10-Q · 7 Aug 2026
Q1 2026	$16.29B	Unavailable	−$4.24B	−$1.72	10-Q · 4 May 2026
Q4 2025	$16.40B	Unavailable	$2.96B	Unavailable	10-K · 24 Feb 2026
Q3 2025	$17.28B	Unavailable	$5.79B	$2.32	10-Q · 5 Nov 2025
Q2 2025	$15.81B	Unavailable	$4.43B	$1.76	10-Q · 5 Aug 2025
Q1 2025	$15.53B	Unavailable	$5.08B	$2.01	10-Q · 2 May 2025

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Buy

Target: $159.76

6.6% upside potential

📈

Strong Buy

Unavailable

👍

Buy

15

⏸️

Hold

6

📉

Sell

0

21 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved 21 Oct 2026, 22:48 UTC Targets range 105.00–180.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments

Verified Dividend Data Unavailable

Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable

Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity

13

Aug 2026

Guindo Chirfi

EVP, Access, Policy & Comms

Open-market sale

$135.00 per share

10,000 shares

12

Aug 2026

Zachary Jennifer

EVP, General Counsel

Option exercise

$109.78 per share

54,927 shares

12

Aug 2026

Zachary Jennifer

EVP, General Counsel

Open-market sale

$133.46 per share

80,315 shares

12

Aug 2026

DeLuca Richard R.

EVP&Pres, Merck Animal Heallth

Open-market sale

$131.63 per share

11,699 shares

11

Aug 2026

DeLuca Richard R.

EVP&Pres, Merck Animal Heallth

Open-market sale

$131.76 per share

12,837 shares

10

Aug 2026

DeLuca Richard R.

EVP&Pres, Merck Animal Heallth

Open-market sale

$130.43 per share

20,784 shares

6

Aug 2026

DeLuca Richard R.

EVP&Pres, Merck Animal Heallth

Open-market sale

$130.38 per share

6,050 shares

5

Aug 2026

Maraldo David R.

EVP & Pres. MMD

Option exercise

$82.25 per share

18,706 shares

5

Aug 2026

Maraldo David R.

EVP & Pres. MMD

Open-market sale

$128.72 per share

18,706 shares

Top Shareholders

Vanguard Group Inc

254,322,763 shares

0.867% change

12/31/2025

Blackrock, Inc.

226,999,837 shares

0.518% change

6/30/2026

Vanguard Capital Management Llc

161,323,174 shares

0.208% change

6/30/2026

State Street Corp

120,413,256 shares

0.911% change

6/30/2026

Wellington Management Group Llp

86,249,283 shares

2.294% change

6/30/2026

Vanguard Portfolio Management Llc

67,738,969 shares

0.646% change

6/30/2026

Geode Capital Management, Llc

60,744,214 shares

1.991% change

6/30/2026

Charles Schwab Investment Management Inc

54,365,289 shares

9.244% change

6/30/2026

Morgan Stanley

48,641,158 shares

2.118% change

6/30/2026

Fmr Llc

45,440,355 shares

2.076% change

6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed 21 Oct 2026, 22:48 UTC· 8 hours ago

Research coverage and investment tools

Merck & Co., Inc. (MRK) is a stock listed on the New York Stock Exchange in the United States, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). Its last price was US$149.88 on 21 Oct 2026. That is 91% of the way from its 52-week low of US$82.01 to its 52-week high of US$156.92. It paid US$3.40 a share in dividends over the last 12 months, a dividend yield of 2.29%. The latest ex-dividend date on file is 15 Sep 2026. Its market capitalisation was US$369.78 billion at that price.

Watch Add to portfolio Set an alert Compare Position size

How position sizing works Dividend yield and total return

Quarter	Revenue	Operating income	Net income	Diluted EPS	Gross margin	Operating margin	Free cash flow	Filed
Q2 2026	$16.61B	Unavailable	−$1.34B	−$0.54	—	—	$4.48B	10-Q · 7 Aug 2026 (opens in a new tab)
Q1 2026	$16.29B	Unavailable	−$4.24B	−$1.72	—	—	$2.93B	10-Q · 4 May 2026 (opens in a new tab)
Q4 2025	$16.40B	Unavailable	$2.96B	Unavailable	—	—	$1.82B	10-K · 24 Feb 2026 (opens in a new tab)
Q3 2025	$17.28B	Unavailable	$5.79B	$2.32	—	—	$6.84B	10-Q · 5 Nov 2025 (opens in a new tab)
Q2 2025	$15.81B	Unavailable	$4.43B	$1.76	—	—	$2.53B	10-Q · 5 Aug 2025 (opens in a new tab)
Q1 2025	$15.53B	Unavailable	$5.08B	$2.01	—	—	$1.17B	10-Q · 2 May 2025 (opens in a new tab)

Quarter ended	Reported	EPS	Consensus	Surprise
Jun 2026	8/4/2026	−$0.13	−$0.26	+50.0%
Mar 2026	4/30/2026	−$1.28	−$1.51	+15.2%
Dec 2025	2/3/2026	$2.04	$2.03	+0.5%
Sep 2025	10/30/2025	$2.58	$2.36	+9.3%

Cash and equivalents: $6.85B
Total assets: $129.80B
Shareholders' equity: $41.93B
Long-term debt: $51.08B
Debt due within a year: $2.83B

25-NSE · 15 Oct 2026 · Delisting Completed

Merck & Co., Inc. filed Form 25-NSE (opens in a new tab)

Merck & Co., Inc. submitted Form 25-NSE to the SEC.
8-K · 13 Oct 2026 · Management change

Merck & Co., Inc. reported A director or senior management change or compensation event (opens in a new tab)

Merck & Co., Inc. filed an 8-K covering a director or senior management change or compensation event.
10-Q · 8 Aug 2026

Merck & Co., Inc. filed Form 10-Q (opens in a new tab)

Merck & Co., Inc. submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.
8-K · 4 Aug 2026

Merck & Co., Inc. reported Operating or financial results (opens in a new tab)

Merck & Co., Inc. filed an 8-K covering operating or financial results, supporting financial statements or exhibits.
8-K · 29 May 2026

Merck & Co., Inc. reported Shareholder voting results (opens in a new tab)

Merck & Co., Inc. filed an 8-K covering shareholder voting results.

Insider	Date	Transaction	Shares	Average price	Filing
Guindo Chirfi EVP, Access, Policy & Comms	13 Aug 2026	Open-market sale (S)	−10,000	$135.00	Form 4 (opens in a new tab)
Zachary Jennifer EVP, General Counsel	12 Aug 2026	Option exercise (M)	+54,927	$109.78	Form 4 (opens in a new tab)
Zachary Jennifer EVP, General Counsel	12 Aug 2026	Open-market sale (S)	−80,315	$133.46	Form 4 (opens in a new tab)
DeLuca Richard R. EVP&Pres, Merck Animal Heallth	12 Aug 2026	Open-market sale (S)	−11,699	$131.63	Form 4 (opens in a new tab)
DeLuca Richard R. EVP&Pres, Merck Animal Heallth	11 Aug 2026	Open-market sale (S)	−12,837	$131.76	Form 4 (opens in a new tab)
DeLuca Richard R. EVP&Pres, Merck Animal Heallth	10 Aug 2026	Open-market sale (S)	−20,784	$130.43	Form 4 (opens in a new tab)
DeLuca Richard R. EVP&Pres, Merck Animal Heallth	6 Aug 2026	Open-market sale (S)	−6,050	$130.38	Form 4 (opens in a new tab)
Maraldo David R. EVP & Pres. MMD	5 Aug 2026	Option exercise (M)	+18,706	$82.25	Form 4 (opens in a new tab)
Maraldo David R. EVP & Pres. MMD	5 Aug 2026	Open-market sale (S)	−18,706	$128.72	Form 4 (opens in a new tab)

Institution	Report date	Shares	Change
Vanguard Group Inc	12/31/2025	254,322,763	0.867%
Blackrock, Inc.	6/30/2026	226,999,837	0.518%
Vanguard Capital Management Llc	6/30/2026	161,323,174	0.208%
State Street Corp	6/30/2026	120,413,256	0.911%
Wellington Management Group Llp	6/30/2026	86,249,283	2.294%
Vanguard Portfolio Management Llc	6/30/2026	67,738,969	0.646%
Geode Capital Management, Llc	6/30/2026	60,744,214	1.991%
Charles Schwab Investment Management Inc	6/30/2026	54,365,289	9.244%
Morgan Stanley	6/30/2026	48,641,158	2.118%
Fmr Llc	6/30/2026	45,440,355	2.076%

Previous close: 148.30 USD
Day range: 147.11 – 150.00 USD
52-week range: 82.01 – 156.92 USD
Volume: 9,004,057
Market cap: $369.78B
Average volume: 8,553,358
P/E ratio: 116.5
EPS (FY 2025, diluted): 7.28 USD
Dividends (last 12 months): 3.40 USD
Dividend yield: 2.29%
Ex-dividend date: 15 Sep 2026
Shares outstanding: 2.47B
Beta (5Y monthly): 0.11

Price, ranges and volume: Yahoo Finance (opens in a new tab) Observed 21 Oct 2026, 20:04 UTC· 11 hours ago

Average volume and shares: Nasdaq (opens in a new tab) Observed 22 Oct 2026, 06:11 UTC· 1 hour ago

Dividends: Yahoo Finance dividend history (opens in a new tab) Observed 22 Oct 2026, 06:11 UTC· 1 hour ago

P/E is market cap ÷ trailing 12-month net income from SEC filings.

EPS: SEC EDGAR company facts (opens in a new tab)

Beta: 5 years of monthly returns against the S&P 500, calculated from Yahoo Finance prices. Market cap is the price × shares outstanding. What dividend yield leaves out: dividend yield vs total return

This research is not available for MRK yet

Guidance history

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.